Brief: Jagsonpal Pharmaceuticals To Buy Wellness Portfolio Of Group Pharmaceuticals
23/09/2026 13:35
BRIEF-Jagsonpal Pharmaceuticals To Buy Wellness Portfolio Of Group Pharmaceuticals Sept 23 (Reuters) - Jagsonpal Pharmaceuticals Ltd JGSN.NS:
JAGSONPAL PHARMACEUTICALS - TO BUY WELLNESS PORTFOLIO OF GROUP PHARMACEUTICALS
JAGSONPAL PHARMACEUTICALS - TOTAL CONSIDERATION CAP OF 467 MILLION RUPEES FOR THE DEAL
JAGSONPAL PHARMACEUTICALS - TRANSACTION IS EXPECTED TO BE COMPLETED ON OR BEFORE 01 NOVEMBER, 2026
Source text: ID:nBSE6CWM70
Further company coverage: JGSN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jagsonpal Pharmaceuticals
See all newsIndia's Jagsonpal Pharma jumps on purchase of wellness portfolio of Group Pharma
Brief: Jagsonpal Pharmaceuticals To Buy Wellness Portfolio Of Group Pharmaceuticals
Brief: Jagsonpal Pharmaceuticals Passes Buy-Back Resolution
Brief: Jagsonpal Pharmaceuticals Gets Order For Tax Demand Of 48.2 Million Rupees
India's Jagsonpal Pharmaceuticals jumps after plan to buyback shares